Federal contractors / BIORELIANCE CORPORATION

Federal contract award

75D30124P19870

FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeCDC OFFICE OF ACQUISITION SERVICES
NAICS621511 — Medical Laboratories
PSCQ301 — Reference Laboratory Testing
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$248.8K
Current contract value$248.8K
Potential contract value / ceiling$248.8K
Start dateSep 26, 2024
Current end dateSep 24, 2026
Potential end dateSep 24, 2026
Latest award activityJun 9, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 9, 2026P00003$0EO 14398
Jun 16, 2025P00002$0FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.
Nov 1, 2024P00001$0FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.
Sep 26, 20240$248.8KFOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Dawnnia DaleyContactxwf5@cdc.gov
4044986079		SourceAug 21, 2024
Liubov KrielContactvyh1@cdc.gov
7704882856		SourceAug 21, 2024
Dawnnia DaleyContactxwf5@cdc.gov
4044986079		SourceAug 19, 2024
Liubov KrielContactvyh1@cdc.gov
7704882856		SourceAug 19, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.